- Home
- CRIS vs CYCU Comparison
CRIS vs CYCU Comparison
Compare CRIS & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- CYCU
- Stock Information
- Founded
- CRIS 2000
- CYCU 2017
- Country
- CRIS United States
- CYCU United States
- Employees
- CRIS N/A
- CYCU N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- CYCU
- Sector
- CRIS Health Care
- CYCU
- Exchange
- CRIS Nasdaq
- CYCU Nasdaq
- Market Cap
- CRIS 18.6M
- CYCU 17.8M
- IPO Year
- CRIS 2000
- CYCU N/A
- Fundamental
- Price
- CRIS $1.14
- CYCU $4.29
- Analyst Decision
- CRIS Strong Buy
- CYCU
- Analyst Count
- CRIS 2
- CYCU 0
- Target Price
- CRIS $16.50
- CYCU N/A
- AVG Volume (30 Days)
- CRIS 75.6K
- CYCU 2.3M
- Earning Date
- CRIS 11-06-2025
- CYCU 11-13-2025
- Dividend Yield
- CRIS N/A
- CYCU N/A
- EPS Growth
- CRIS N/A
- CYCU N/A
- EPS
- CRIS N/A
- CYCU N/A
- Revenue
- CRIS $11,650,000.00
- CYCU $16,285,283.00
- Revenue This Year
- CRIS $2.72
- CYCU N/A
- Revenue Next Year
- CRIS $8.27
- CYCU N/A
- P/E Ratio
- CRIS N/A
- CYCU N/A
- Revenue Growth
- CRIS 13.56
- CYCU N/A
- 52 Week Low
- CRIS $1.02
- CYCU $2.15
- 52 Week High
- CRIS $4.70
- CYCU $329.70
- Technical
- Relative Strength Index (RSI)
- CRIS 20.03
- CYCU 72.72
- Support Level
- CRIS $1.21
- CYCU $3.01
- Resistance Level
- CRIS $1.35
- CYCU $3.60
- Average True Range (ATR)
- CRIS 0.09
- CYCU 0.62
- MACD
- CRIS -0.03
- CYCU 0.07
- Stochastic Oscillator
- CRIS 1.92
- CYCU 71.73
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About CYCU Cycurion Inc. Common Stock
Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).